Overview
Sanofi, headquartered in Paris, researches, produces and distributes pharmaceutical products and now reports a single Biopharma segment that includes specialty care, general medicines and vaccines franchises.[2] Forbes records sales of US$49.2bn, up 10.8% on the prior-year figure, profit of US$5.9bn and a market value of US$103.2bn.[2] The company is France’s largest drug maker and keeps eleventh place in this ranking, unchanged from the prior-year comparison. Its vaccines franchise, which includes influenza and paediatric vaccines, competes with GSK, Merck & Co. and Pfizer. Forbes gives its founding year as 1973 and counts 76,493 employees.[2]
Sanofi strengths and limitations
Strengths
- Double-digit sales growth
- Large vaccines franchise
- Single-segment reporting after consumer-health separation
Limitations
- Profit margin about 12%
- General-medicines portfolio faces price pressure
- Market value lower than peers of similar size
Appears in
Sanofi peers and competitors
Companies ranked in the same lists as Sanofi.
Johnson & Johnson
Takeda Pharmaceutical
Daiichi Sankyo- Astellas Pharma
Viatris- Regeneron Pharmaceuticals
- CSL
Otsuka Holdings- Teva Pharmaceutical
Merck KGaA
Gilead Sciences- Amgen
Is this your company?
Update the description, logo, image and link through the submission form. Editors review every change.